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Lower respiratory tract infections are among the most common causes of death worldwide. Main pathogens
leading to these severe infections are viruses and gram-positive bacteria that activate toll-like receptor (TLR)-
mediated immune responses via pathogen-associated molecular patterns. One protective factor induced during
infection is Chitinase-3-like 1 (CHI3L1), which exerts various functions, e.g. in host cell proliferation and bac-
terial counteraction, and has been proposed as a biomarker in several acute and chronic inflammatory condi-
tions. MicroRNAs (miR) have become important regulators of inflammation and infection and are considered
therapeutic targets in recent years. However, it is not known whether microRNAs play a role in the regulation of
CHI3L1 expression in TLR-mediated respiratory epithelial cell inflammation. In this study, we analysed the pre-
and post-transcriptional regulation of CHI3L1 by TLRs in bronchial epithelial cells. Therefore, we stimulated
BEAS-2B cells with the bacterial TLR2-ligand lipoteichoic acid or the viral dsRNA analogue poly(I:C). We ob-
served an increase in the expression of CHI3L1, which was dependent on TNF-α-mediated NF-κB activation in
TLR2- and TLR3-activated cells. Moreover, TLR2 and− 3 stimulation caused downregulation of the microRNA
miR-149-5p, an effect that could be suppressed by inhibiting NF-κB translocation into the nucleus. Luciferase
reporter assays identified a direct interaction of miR-149-5p with the CHI3L1 3´untranslated region. This in-
teraction was confirmed by inhibition and overexpression of miR-149-5p in BEAS-2B cells, which altered the
expression levels of CHI3L1 mRNA. In summary, miR-149-5p directly regulates CHI3L1 in context of TLR-
mediated airway epithelial cell inflammation and may be a potential therapeutic target in inflammation and
other diseases.
1. Introduction
Pulmonary infections such as pneumonia are among the leading
causes of deaths worldwide. Major causative pathogens are gram-
positive Streptococcus pneumoniae (S. pneumoniae) or Influenza A Virus
[1,2]. During infection epithelial cells recognize pathogen-associated
molecular patterns (PAMPs) via pattern recognition receptors such as
toll-like receptors (TLRs) and orchestrate the inflammatory host
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response [3]. Important PAMPs are e.g. lipoteichoic acid (LTA) and
RNA or DNA from bacteria and viruses that specifically activate certain
TLR signalling cascades [4–6]. LTA from gram-positive Staphylococcus
aureus (S. aureus) activates TLR2 complexes [7]. After ligand recogni-
tion, TLR2 signals via MyD88 (Myeloid Differentiation Primary Re-
sponse 88), IRAK1 (Interleukin 1 Receptor Associated Kinase 1) and
TRAF6 (TNF Receptor Associated Factor 6) to IKK (IκB kinase) protein
kinase complex [8]. Here, IĸBα (Nuclear Factor of kappa light poly-
peptide gene enhancer in B-cells inhibitor, alpha) is phosphorylated and
degraded enabling the translocation of NF-κB (Nuclear Factor kappa B)
to the nucleus [9]. Subsequently, NF-κB induces expression of pro-in-
flammatory cytokines such as CXCL8 (C-X-C Motif Chemokine Ligand
8) and IL-1β (Interleukin 1 Beta). In contrast to bacterial PAMPs, viral
dsRNA mimic polyinosinic:polycytidylic acid (poly(I:C)) is recognized
by TLR3 [10], which directly interacts with TRIF (TICAM1, Toll Like
Receptor Adaptor Molecule 1). Thereby, it can activate either IRF3
(Interferon Regulatory Factor 3) via TBK1 (TANK Binding Kinase 1) to
mount an IFN-β (IFNB1, interferon beta 1) response or NF-κB via RIPK1
(Receptor Interacting Serine/Threonine Kinase 1) and IKK to induce the
expression of pro-inflammatory cytokines as for TLR2 [11].
Chitinase-3-like 1 (CHI3L1) is an important NF-κB-dependent host
factor and a biomarker for both, acute and chronic inflammation
[12–16]. CHI3L1 is a chitinase-like protein with a glycosyl hydrolase 18
domain which, unlike real chitinases, can bind chitin but cannot cleave
it due to amino acid modifications in the catalytic domain [17]. In a
cellular context, CHI3L1 protein is involved in several processes, for
instance proliferation, adhesion and cell migration, and is secreted by
different cell types including colonic epithelial cells [18–21]. Ad-
ditionally, CHI3L1 is involved in repair of epithelium and in bacterial
counteraction [19,22–25]. In this regard, CHI3L1 knockout mice were
more sensitive to S. pneumoniae infection compared to wildtype mice
[23].
MicroRNAs (miRNAs or miRs) are small, non-coding RNAs with a
length of 21 to 23 base pairs [26,27]. They are transcribed as pri-
miRNAs in the nucleus, processed to pre-miRNAs and subsequently
exported into the cytoplasm where they are cleaved [28–32]. The ma-
ture miRNA binds mainly to 3`untranslated regions (UTR) of its target
mRNAs with its corresponding seed region at nucleotide position 2 to 8.
MiRNA function is coupled to post-transcriptional regulation such as
mRNA stability or translational enhancement [33–35]. In the last dec-
ades, miRNA function was demonstrated to be important in various
diseases such as diverse cancers, chronic inflammation, as observed in
chronic obstructive pulmonary disease or asthma, and acute in-
flammation after infection. For instance, in lipopolysaccharide induced
acute inflammation the expression of miR-146a is activated in human
monocytes through NF-κB and downregulates IRAK1 acting as an anti-
inflammatory miRNA [36]. In Hepatitis C Virus infection in hepato-
cytes, NOTCH1 (Notch receptor 1) is post-transcriptionally regulated by
miR-449a [37]. Thereby, NOTCH1 induces TNF-α-mediated NF-κB ac-
tivation and stimulates CHI3L1 expression. In osteomyelitis caused by
Staphylococcus aureus, miR-24 was identified to regulate CHI3L1 ex-
pression by binding to its 3` UTR [38]. Additionally, miR-24 suppresses
CHI3L1 expression during S. aureus-induced macrophage polarization
[39]. Besides miR-24/CHI3L1 miRNA-target interaction, little is known
regarding miRNA-mediated regulation of CHI3L1.
In this study, we wanted to elucidate how the expression pattern of
CHI3L1 is influenced upon TLR2 and TLR3 activation in human bron-
chial epithelial cells and whether miRNAs (miR-24-3p, miR-30d, miR-
125a-3p, miR-149-5p) are involved in its regulation. We used ligand
stimulations to activate TLR2 and TLR3 signalling and investigated the
involved signalling pathway, tested miRNA/mRNA interaction using
the luciferase reporter assay, and overexpressed or inhibited putative
miRNAs in host cells to explore the direct influence on CHI3L1 ex-
pression. Our study contributes to the understanding of the post-tran-
scriptional regulation of CHI3L1 and thus provides starting points for
therapeutic purposes in the fight against inflammation.
2. Material and methods
2.1. Cell culture, stimulation and inhibitor treatments
Human bronchial epithelial BEAS-2B cells were purchased from
ATCC® (CRL-9609™) and cultured as described in manufacturer's in-
structions with following exceptions. Supplement GA-1000 of BEBM
Supplements (CC-4175, Lonza) was not used and flasks were not
coated. Cells were cultured at 37 °C and 5% CO2. For stimulation ex-
periments, 1.5*105 BEAS-2B cells were seeded per 12well. After 48 h
cells were treated with indicated amounts of human recombinant TNF-
α (R&D Systems), or purified lipoteichoic acid (LTA) from
Staphylococcus aureus (InvivoGen; TLR2 ligand) or poly(I:C) (InvivoGen;
TLR3 ligand) for 24 h. RNA samples (quantitative RT-PCR) or super-
natants (ELISA) were collected. For immunofluorescence staining, cells
were stimulated with LTA for 2 h or poly(I:C) for 4 h. Please note that
the commercially available LTA from S. aureus, which we used in this
study, was shown to be contaminated with lipopeptide that is re-
sponsible for TLR2 activation [40]. For inhibitor experiments, BEAS-2B
cells were pre-treated with 5 μM BAY11–7082 (Merck Millipore) dis-
solved in dimethyl sulfoxide (DMSO, Carl Roth GmbH+ Co. KG) for 1 h
before stimulation.
The human lung epithelial cell line A549 was purchased from
ATCC® (CCL-185) and cultured in Ham's F-12 Nutrient Mix, GlutaMAX™
Supplement (Thermo Fisher Scientific) supplemented with 10% fetal
calf serum (FCS superior, Biochrom GmbH). Cells were cultured at 37 °C
and 5% CO2.
2.2. Transfection of miRNA mimic and inhibitor
For mirVana™ miRNA inhibitor or mimic transfection, 1.2*105
BEAS-2B cells or 1.5*105 A549 cells per 24well were reverse trans-
fected with 10 pmol inhibitor or mimic for miR-149-5p
(MIMAT0000450; MH12788, MC12788) as well as mirVana™ miRNA
inhibitor and mirVana™ miRNA mimic negative control #1 (NEG) by
Lipofectamine™ RNAiMax (Thermo Fisher Scientific) according to
manufacturer's instructions using Opti-MEM™ (Thermo Fisher
Scientific). If indicated, cells were mock- or LTA-stimulated after 18 h of
transfection for additional 24 h.
2.3. Generation of vectors
To generate a CHI3L1 3′UTR wildtype (3′UTR CHI3L1 WT) con-
taining vector for luciferase reporter assay, genomic DNA from BEAS-
2B cells was used as a template in PCR reaction. The insert was am-
plified by hCHI3L1_3′UTR forward (fwd, 5′ CGACTCGAGCCCTCTGTT
CTGCACACAGC 3′) and reverse primers (rev, 5′ CGAGCGGCCGCCAC
TGTTAAGCTCTTGTAC 3′; Metabion International AG) that contain
XhoI and NotI restriction sites (underlined, New England Biolabs), re-
spectively, for integration into the vector backbone psiCHECK™-2
multiple cloning site (Promega). For generating mutations in seed se-
quences of respective miRNAs, we synthesized mutated CHI3L1 3′UTR
fragments with restriction sites XhoI and NotI (gBlocks® Gene
Fragments, Integrated DNA Technologies, Inc.) and integrated them
into psiCHECK™-2 vector. All vectors were ligated with T4 DNA Ligase
following manufacturer's instructions (New England Biolabs), trans-
formed into TOP10 E. coli and plated on LB agar (Carl Roth GmbH+ Co
KG) plates containing 100 μg/mL ampicillin (Carl Roth GmbH + Co
KG) for selection. All generated vectors were confirmed by sequencing
(Sequencing Service, LMU Munich).
2.4. Luciferase reporter assay
Dual-Glo® Luciferase Reporter Assay (Promega) was used as de-
scribed in manufacturer's instructions with following modifications.
A549 cells (1.5*105) were reverse transfected with Lipofectamine 2000
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(Thermo Fisher Scientific) in a 24well format using 200 ng vector and
10 pmol miRNA mimic. PsiCHECK™-2 served as empty vector control.
Measurements of luciferase luminescence were performed 48 h post
transfection using Tecan Infinite® M200 PRO plate reader (Tecan). The
relative luciferase activity was presented as the relative response ratio
of the firefly luciferase as a transfection control and Renilla luciferase.
Normalization was calculated using A549 cells transfected with empty
vector control and miRNA mimic negative control.
2.5. RNA extraction and quantitative reverse-transcription polymerase
chain reaction (RT-PCR)
Total RNA from cells was extracted by phenol-chloroform based
method using Isol-RNA Lysis Reagent (5`Prime, Hamburg, Germany)
according to the manufacturer's instructions. RNA was reverse tran-
scribed using either TaqMan MicroRNA Reverse Transcription Kit or
High-Capacity RNA-to-cDNA kit following manufacturer's instructions
(Thermo Fisher Scientific), followed by quantitative RT-PCR with
ViiA7™ System and QuantStudio™ Design & Analysis Software v1.3.1
(Thermo Fisher Scientific) according to manufacturer's instructions.
MicroRNAs were quantified using TaqMan Fast Advanced Master Mix
(miR-146a-5p ID000468, miR-149-5p ID002255, miR-24-3p ID000402,
RNU48 ID001006, Thermo Fisher Scientific). Expression of mRNAs
were quantified using Fast SYBR™ Green Master Mix (Thermo Fisher
Scientific) or Luna® Universal qPCR Master Mix (New England Biolabs)
together with specific primer pairs (CHI3L1 fwd 5` CTGGTGCTGCTCC
AGTGC 3`, rev 5` GAAGCGGTCAAGGGCATCT 3`; CXCL8 fwd 5` ACT
GAGAGTGATTGAGAGTGGAC 3`, rev 5` AACCCTCTGCACCCAGTTTTC
3`; TNF-α fwd 5` GCTGCACTTTGGAGTGATCG 3`, rev 5` TCACTCGG
GGTTCGAGAAGA 3`; GAPDH fwd 5` CCACATCGCTCAGACACCAT 3`,
rev 5` CGCAACAATATCCACTTTACCAGAG 3`; Metabion International
AG). The x-fold expression was calculated using the 2−ΔΔct method and
quantitative RT-PCR results were normalized to the corresponding
control cells [41].
2.6. Enzyme-linked Immunosorbent assay (ELISA)
Protein release of CHI3L1 in the supernatants of stimulated BEAS-2B
cells was analysed using Human Chitinase-3-like 1 DuoSet ELISA ac-
cording to manufacturer's instructions (R&D systems, Inc.). All mea-
surements were performed in duplicates using Tecan Infinite® M200
PRO plate reader (Tecan).
2.7. Immunofluorescence
BEAS-2B cells were seeded with 3.5*104 cells on sterile glass cover
slips in 24well plates for 72 h. After treatment or stimulation cover slips
underwent three washing steps with 1× PBS (GE Healthcare Life
Science) followed by fixation with 4% paraformaldehyde (Carl Roth
GmbH + Co. KG) for 10min at room temperature. For intracellular
protein detection, cells were permeabilized with 0.1% Triton X-100
(Carl Roth GmbH + Co. KG) in 1× PBS for 10min followed by three
washing steps with 1× PBS. Primary antibody (anti-p65-rabbit-IgG,
Santa Cruz Biotechnology) diluted 1:50 in 0.35% BSA/PBS (fraction V,
Carl Roth GmbH + Co. KG) was added and incubated in a humidified
chamber for 2 h at room temperature. After additional three washing
steps cells were incubated with secondary antibody (goat anti-rabbit
IgG, Alexa-Fluor® 555, Thermo Fisher Scientific) followed by three
washing steps. Consecutively, cells were stained for nucleic acids with
DAPI (4`,6-Diamidino-2-phenylindol, ATT Bioquest, dilution 1:5000 in
ultrapure H2O, Biochrom) for 10min and Phalloidin (Alexa Fluor 488,
Thermo Fisher Scientific) as described in manufacturer's protocol. Cells
were washed twice with water, mounted with Mowiol (4–88, Carl Roth
GmbH + Co. KG) on a slide and dried overnight at 4 °C prior to mi-
croscopy with Axio Vert A1 and Axio Cam MRm (Carl Zeiss, Jena,
Germany), Kübler codix HXP120C and Axio Vision SE64 Rel.4.8.
Overlay images were generated using Image J (Fiji, Version 2).
2.8. Statistical analysis
Significance was statistically evaluated using the indicated analysis
tools provided by GraphPad PRISM 6 software (San Diego, CA). Log2-
transformed data were used for quantitative RT-PCR fold changes and
ELISA analysis. P values of< 0.05 were considered statistically sig-
nificant.
3. Results
3.1. TLR2 and TLR3 activation induce CHI3L1 expression in an NF-κB
dependent manner in BEAS-2B cells
To examine the expression of CHI3L1 during bacterial and viral
infection of the respiratory epithelium, we first investigated the ex-
pression of CHI3L1 mRNA and protein in a setting similar to respiratory
infections in TLR2- and TLR3-activated human bronchial epithelial
cells. Therefore, we stimulated the bronchial epithelial cell line BEAS-
2B with two different TLR activators, namely S. aureus lipoteichoic acid
(LTA, [42]), and a virus-like stimulus poly(I:C) (pIC, [43]). As a control
for inflammatory response upon TLR2 and− 3 activation, we observed
significant increases in CXCL8 mRNA and protein expression (Suppl.
Fig. S1). Compared to mock-treated control cells, both, LTA and poly
(I:C)-treated cells showed significant increases in CHI3L1 mRNA ex-
pression and protein release into the medium (Fig. 1). In particular, LTA
treatment resulted in a 20-fold and 3-fold increase of CHI3L1 mRNA
expression and protein release, respectively (Fig. 1A, B). In addition, we
investigated a second TLR2 agonist, Pam3CSK4, and obtained similar
results as seen for LTA stimulation experiments (Suppl. Fig. S2). For
poly(I:C), we observed an 8-fold induction of mRNA expression and a
2.5-fold increase in CHI3L1 protein release (Fig. 1C, D). Thus, CHI3L1
expression is strongly upregulated in bronchial epithelial cells following
TLR2 and TLR3 activation.
CHI3L1 expression in hepatocytes is regulated by TNF-α, as re-
vealed by Sarma et al. (2012) [37]. Therefore, we analysed how LTA
and poly(I:C) influence the expression of TNF-α mRNA in bronchial
epithelial cells and how TNF-α stimulation in turn affects CHI3L1 ex-
pression. In both stimulation experiments, TNF-αmRNA expression was
induced up to 40-fold by both concentrations of LTA and the highest
concentration of poly(I:C) (Fig. 2A, B). Consistently, stimulation of
BEAS-2B cells with TNF-α resulted in an up to 12-fold induction of
CHI3L1 mRNA expression and a 3-fold increase in protein release
compared to mock-treated cells (Fig. 2C, D).
To determine, which signalling pathway is involved in CHI3L1
mRNA and protein expression, we tested different inhibitors to block
p38/MAPK (SB202190), ERK1/2 (U0126), TAK1 (5Z-7-Oxozeanol) as
well as TNF-α-mediated phosphorylation of IĸBα (BAY11–7082) for
subsequent inhibition of NF-κB translocation to the nucleus [44], and
stimulated these BEAS-2B cells with poly(I:C) or LTA. Cytotoxicity
analysis revealed>95% viable cells in all treatments (Suppl. Fig. S3A).
As a control we tested CXCL8 mRNA expression and observed an ex-
pected and strong decrease in TAK1-inhibited cells upon poly(I:C) and
LTA stimulation and in BAY11–7082-inhibited cells upon poly(I:C)
stimulation compared to DMSO-treated control cells (Suppl. Fig. S3B).
Additionally, we investigated NF-κB translocation to the nucleus, which
can be blocked by BAY11–7082, by immunofluorescence microscopy
using anti-p65 for NF-κB detection (Fig. 3A). In mock-treated BEAS-2B
cells, p65 was mainly located in the cytosol whereas, upon TLR2 or
TLR3 activation, p65 was mainly translocated to the nucleus as ex-
pected. After inhibition of TNF-α-mediated IκBα-phosphorylation by
BAY11–7082, nuclear translocation of NF-κB was blocked in both,
mock-treated and stimulated cells.
While p38/MAPK and ERK1/2 inhibition did not change CHI3L1
mRNA and protein expression upon stimulation with poly(I:C) or LTA
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(Suppl. Fig. S3C, D), TAK1 inhibitor and BAY11–7082-treated cells
significantly reduced CHI3L1 mRNA expression and protein release to
about 50% in LTA and poly(I:C)-stimulated BEAS-2B cells compared to
mock-treated cells (Fig. 3B-D, Suppl. Fig. 3C, D).
In summary, CHI3L1 expression is induced upon TLR2 and TLR3
activation and can be suppressed by blocking TAK1 signalling pathway
or TNF-α-mediated NF-κB translocation to the nucleus in human
bronchial epithelial cells.
3.2. TLR2 and TLR3 activation cause NF-κB-dependent downregulation of
miRNA-149-5p in BEAS-2B cells
MicroRNAs are known as important regulators of mRNA targets in
infectious diseases. Based on different miRNA-target prediction
Fig. 1. CHI3L1 mRNA levels and protein release are increased
upon TLR2 and TLR3 activation in BEAS-2B cells. (A, B)
BEAS-2B cells were stimulated with indicated concentrations
of lipoteichoic acid (LTA) from S. aureus or left untreated as a
control (CTR). (A) Quantitative RT-PCR for CHI3L1 mRNA
expression. (B) ELISA for CHI3L1 protein quantification. (C,
D) BEAS-2B cells were stimulated with indicated concentra-
tions of poly(I:C) (pIC) or left untreated as control. (C)
Quantitative RT-PCR for CHI3L1 mRNA expression. (D) ELISA
for CHI3L1 protein quantification. Expression of mRNA was
normalized to endogenous GAPDH expression and un-
stimulated control. N=4. Stats were calculated using log2-
transformed data. Ordinary one-way ANOVA using Holm-
Sidak multiple comparisons test. *p < .05; ***p < .001;
****p < .0001. Shown are whisker plots (whisker at min/
max).
Fig. 2. TLR-mediated TNF-α induction increases CHI3L1 ex-
pression in BEAS-2B cells. (A, B) Quantitative RT-PCR for
TNF-α expression in LTA or pIC stimulated BEAS-2B cells
using indicated concentrations for 24 h. (C, D) BEAS-2B cells
were stimulated with indicated concentrations of TNF-α for
24 h. (C) Quantitative RT-PCR for CHI3L1 mRNA expression.
Expression was normalized to endogenous GAPDH expression
and unstimulated control. (D) ELISA for CHI3L1 quantifica-
tion. N≥ 3. Stats were calculated using log2-transformed
data. Ordinary one-way ANOVA using Holm-Sidak multiple
comparisons test. *p < .05; **p < .01; ***p < .001;
****p < .0001. CTR, untreated control. Shown are floating
bars with line at mean.
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databases, we found that miRNAs miR-24-3p, miR-30d, miR-125a-3p
and miR-149-5p were predicted to bind in the 3`UTR of CHI3L1 (Suppl.
Table S1). To investigate the miRNA-dependent regulation of CHI3L1
expression in TLR2- and TLR3-activated BEAS-2B cells, we first de-
termined the abundance of these miRNAs in LTA, poly(I:C), or TNF-α-
stimulated cells via quantitative RT-PCR. Additionally, we investigated
the involvement of NF-κB activation on this miRNA using BAY11–7082
inhibitor. As a control, we analysed miR-146a-5p, which is known to be
upregulated upon an inflammatory stimulus [45].
As expected, our results revealed that miR-146a-5p was strongly
upregulated post LTA, poly(I:C) and TNF-α stimulation with the
strongest induction of 150-fold upon LTA treatment (Fig. 4A-C). Since
miR-146a-5p is known to be activated via NF-κB [36], we also tested
the expression of miR-146a-5p abundance upon BAY11–7082 inhibitor
treatment (Fig. 4D). As anticipated, miR-146a-5p was strongly reduced
by 10-fold in inhibitor-treated, LTA- or poly(I:C)-stimulated cells com-
pared to DMSO-treated cells. The expression of miRNAs miR-30d and
miR-125a-3p did not change significantly in any tested conditions.
Therefore, it was excluded that these miRNAs regulate TLR2- or TLR3-
dependent CHI3L1 expression in BEAS-2B cells (Suppl. Fig. S4). MiR-
24-3p, which was published to interact with CHI3L1 3`UTR in mice
osteoblasts [38], was only significantly reduced post poly(I:C) stimu-
lation (Fig. 4A-D). Interestingly, miRNA-149-5p abundance was
strongly reduced in all tested conditions with a robust reduction down
to 10% in poly(I:C)-stimulated cells (Fig. 4A-C). This reduction was
partially reversed back to 50% using BAY11–7082 inhibitor compared
to DMSO-treated cells (Fig. 4D). Comparable effects on miR-149-5p
levels were detected in inhibitor-treated LTA-stimulated cells.
Taken together, TLR2 and TLR3 activation as well as TNF-α sti-
mulation of BEAS-2B cells strongly reduced miR-149-5p expression,
which was partially restored by inhibiting nuclear translocation of NF-
κB. Notably, CHI3L1 upregulation correlates with miR-149-5p down-
regulation suggesting a regulatory function of miR-149-5p in CHI3L1
mRNA expression.
3.3. MiR-149-5p directly targets the 3`UTR of CHI3L1 and regulates
expression of CHI3L1
To investigate whether miR-149-5p targets the 3`UTR of CHI3L1,
we performed luciferase reporter assays and transfected A549 cells with
luciferase vectors containing different versions of the 3`UTR of CHI3L1
(Fig. 5A). In this regard, we also tried to perform luciferase reporter
assay in BEAS-2B cell line, but very low detection of luciferase activity
eliminated this option. The wildtype (WT) vector contained the whole
CHI3L1 3`UTR (www.ensembl.org, release 95, 514 nucleotides, nt). In
addition, we mutated three putative seed regions (seed positions 4–8 of
miR-149-5p) within the 3`UTR of CHI3L1. To prevent predicted miRNA
binding to the 3’UTR, Mutation (Mut) 1 vector was mutated for the first,
Mut2 vector for the second and Mut3 vector for the third miR-149-5p
seed region (Fig. 5A). Each vector version was co-transfected with the
Fig. 3. Inhibition of TNF-α-mediated p65 translocation to the nucleus reduces CHI3L1 expression upon TLR activation. (A) BEAS-2B cells were pre-treated with
dimethyl sulfoxide (DMSO; 0.005%) or BAY11–7082 (5 μM, INH) for 1 h prior to LTA (1 μg/mL) or pIC (1 μg/mL) stimulation for 2 h or 4 h, respectively, or left
untreated as control (CTR). Subsequent fixed samples were immuno-stained with 4′,6-Diamidin-2-phenylindol (DAPI; blue; nuclei stain), anti-p65 (red) or anti-
Phalloidin (green; F-actin stain). Right column represents the overlay (merge). Arrows indicate examples of no nucleus translocation; asterisks indicate examples of
p65 nucleus translocation. Representative sections are shown. Scale bar= 50 μm. (B) Quantitative RT-PCR for CHI3L1 mRNA expression in BEAS-2B cells pre-treated
with DMSO (0.005%) or BAY11–7082 (5 μM, INH) for 1 h prior to LTA (1 μg/mL) or pIC (1 μg/mL) stimulation for 24 h or left untreated as a control. Expression of
mRNA was normalized to endogenous GAPDH expression and unstimulated control. Shown are floating bars with line at mean. (C, D) ELISA for quantification of
CHI3L1 protein release. BEAS-2B cells were pre-treated with DMSO (0.005%) or BAY11–7082 (5 μM, INH) for 1 h prior to LTA (1 μg/mL) or pIC (1 μg/mL) sti-
mulation for 6 h and 24 h or left untreated as a control. Shown are mean values + SD. N=3. Stats were calculated using log2-transformed data. Two-way ANOVA
using Holm-Sidak multiple comparisons test. *p < .05; **p < .01; ***p < .001; ****p < .0001. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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mimic of miR-149-5p. As controls, we used the empty vector and the
mimic negative control. Overexpression of miR-149-5p led to an ap-
proximately 35% reduction of luciferase activity using WT vector
compared to mimic-control transfected samples (Fig. 5B). While Mut1
and Mut2 did not rescue the luminescence upon miR-149-5p transfec-
tion, Mut3 resulted in a complete luminescence recovery.
Having observed that miR-149-5p directly targets the 3`UTR of
CHI3L1, we next investigated whether the absence or presence of miR-
149-5p function is responsible for regulation of CHI3L1 mRNA abun-
dance. Therefore, we transfected BEAS-2B cells with miR-149-5p in-
hibitor or mimic and subsequently stimulated them with LTA. Analysis
of miR-149-5p expression revealed a reduction down to 75% in un-
treated inhibitor transfected cells compared to control transfected cells
(Fig. 6A). After LTA stimulation, control as well as miR-149-5p in-
hibited cells showed a strong reduction down to 40%. In comparison,
CHI3L1 mRNA expression in unstimulated cells was increased upon
miR-149-5p inhibition, which was further elevated after LTA stimula-
tion up to 12-fold compared to a 9-fold induction in control transfected
cells (Fig. 6B). This observation was further supported by a slight in-
crease of CHI3L1 protein release in LTA stimulated cells (Fig. 6C). Vice
versa, mimicking an overexpression of miR-149-5p showed a strong
abundance of miR-149-5p that was not changed in response to LTA
stimulation (Fig. 6D). CHI3L1 mRNA abundance in turn was strongly
regulated down to 0.15-fold in control-treated cells, while in LTA sti-
mulated cells, CHI3L1 expression increased up to 1-fold, but was still
10-fold reduced compared to control transfected cells (Fig. 6E). In ad-
dition, CHI3L1 protein secretion was significantly reduced in miR-149-
5p overexpressed and LTA stimulated cells compared to control trans-
fected cells (Fig. 6F).
As a control, we further examined the expression of CXCL8 mRNA
Fig. 4. NF-κB inhibition suppresses miRNA-149-5p reduction upon TLR2 and TLR3 activation in BEAS-2B cells. BEAS-2B cells were stimulated for 24 h with (A) LTA,
(B) pIC, (C) TNF-α or left untreated as a control (CTR). In case of inhibitor experiments (D), BEAS-2B cells were pre-treated with DMSO (0.005%) or BAY11–7082
(5 μM, INH) for 1 h prior to LTA (1 μg/mL) or pIC (1 μg/mL) stimulation for 24 h or left untreated as a control (right panel). Shown are quantitative RT-PCR analyses
for determination of miR-146a-5p (left panel), miR-24-3p (middle panel) and miR-149-5p (right panel) abundances. Expression of miRNAs was normalized to
endogenous RNU48 and unstimulated control. N≥ 3. Stats were calculated using log2-transformed data. Ordinary one-way ANOVA using Holm-Sidak multiple
comparisons test (stimulation experiments); Two-way ANOVA using Holm-Sidak multiple comparisons test (inhibition experiments).*p < .05; **p < .01;
***p < .001; ****p < .0001. Shown are floating bars with line at mean.
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and protein. Interestingly, under control conditions, CXCL8 mRNA ex-
pression was slightly upregulated in miRNA inhibitor-transfected cells
and CXCL8 mRNA and protein were significantly downregulated in
miRNA overexpressing cells (Suppl. Fig. 5). In LTA stimulated cells,
CXCL8 protein expression was downregulated in miRNA-inhibited cells
compared to control-transfected cells, while in miRNA-overexpressed
cells CXCL8 mRNA expression was significantly increased. Additionally,
we tested if CHI3L1 treatment influences expression levels of CXCL8
directly. Therefore, we treated BEAS-2B cells with recombinant CHI3L1
(rCHI3L1; 0.2–200 ng/mL) for 4 and 24 h. CHI3L1 treatment did not
change viability of BEAS-2B cells as tested by lactate dehydrogenase
assay (Suppl. Fig. S6A). As a control for a potential feedback loop, we
determined CHI3L1 mRNA expression. After 4 h, a significant increase
in mRNA expression was observed in 20 and 200 ng/mL rCHI3L1
treated cells compared to mock treated cells (Suppl. Fig. S6B). For
CXCL8 mRNA expression, a significant increase was examined after
24 h with 200 ng/mL rCHI3L1 (Suppl. Fig. S6C). However, this in-
creased mRNA expression was not accompanied by increased CXCL8
protein expression (Suppl. Fig. S6D).
In summary, miR-149-5p directly targeted the CHI3L1 3`UTR as
validated by downregulation of luciferase activity in luciferase reporter
assays. Moreover, mutation of the third putative binding site of miR-
149-5p was sufficient to block the interaction with the CHI3L1 3`UTR.
While inhibition of miR-149-5p induced the expression of CHI3L1
mRNA, overexpression of miR-149-5p strongly inhibited CHI3L1 mRNA
expression. In addition, miR-149-5p overexpression enhanced CXCL8
expression in TLR2-activated cells, which was not dependent on CHI3L1
expression, but rather on miR-149-5p overexpression.
4. Discussion
Pneumonia causes high morbidity and mortality in humans and is
the most frequent infectious cause of death in children under 5 years of
age worldwide (World Health Organization, 2019, [46]). In this study,
we focused on human respiratory epithelial cells that respond to lung
infections caused by the toll-like receptors TLR2 and TLR3 signalling.
Therefore, we investigated whether the antibacterial protein CHI3L1 is
post-transcriptionally regulated by miR-149-5p upon TLR2 and TLR3
activation. Our data revealed that miR-149-5p is strongly down-
regulated in TLR2- and TLR3-activated airway epithelial cells to enable
increased CHI3L1 expression. This effect further depends on TLR-
mediated NF-κB translocation into the nucleus. The regulatory potential
of miR-149-5p and CHI3L1 is linked to a direct binding of miR-149-5p
to the CHI3L1 3`UTR, which enables suppression of CHI3L1 expression
and results in an increased inflammatory CXCL8 response.
Our studies revealed that miR-149-5p and CHI3L1 expression de-
pends on TNF-α-mediated NF-κB signalling via IκBα phosphorylation.
These results are consistent with the current knowledge about TLR2-
and TLR3-signalling pathways, which both, despite their different in-
duction, induce translocation of NF-κB to the nucleus [9,47,48]. There,
NF-κB binds to promoter regions of several thousands of target genes to
induce inflammatory responses [49,50]. In addition to induction of
cytokines or chemokines such as CXCL8, also expression of the glyco-
protein CHI3L1 is induced [22]. Thereby, CHI3L1 conducts diverse
Fig. 5. Luciferase reporter assays in A549 cells reveal direct interaction of miR-149-5p and third binding site of CHI3L1 3`UTR. (A) Representation of CHI3L1 3`UTR
position 51 to 130 in upper panel and position 331 to 400 in lower panel from total 3`UTR length of 514 bp. Separated in blocks of 10 nucleotides. Above putative
miRNA binding sites are shown. Vertical black lines represent miRNA binding to 3`UTR. Underlined nucleotides are defined as seed sequences. Mutated (Mut) seed
sequences are highlighted in red. (B) Transfection of A549 cells with either empty vector, wildtype 3`UTR-vector (WT), mutation 1 (Mut1), Mut2- or Mut3-vector and
negative control (NEG), or miR-149-5p. Relative response ratios of Firefly versus Renilla luciferase normalized to empty vector and negative control (NEG) are
shown. N=3. Stats were calculated using log2-transformed data. Two-way ANOVA using Holm-Sidak multiple comparisons test; *p < .05; **p < .01;
***p < .001; ns= not significant. Shown are bars at mean+SD. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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cellular functions that are important in a variety of cell types. Besides
its function in proliferation and differentiation [51,52], especially its
role in infection control was demonstrated. There, CHI3L1 counteracts
invading bacteria in a murine bacterial lung infection model in mac-
rophages as shown for Streptococcus pneumoniae, or is able to kill Can-
dida albicans in mouse cornea infections [23,24].
Additionally to CHI3L1, the role of microRNAs in the regulation of
post-transcriptional processes, e.g. in inflammatory diseases, has been
intensively discussed in the last ten years. In the TLR-mediated in-
flammation model tested here, we identified miR-149-5p to be strongly
downregulated in bronchial epithelial cells during TLR2 and TLR3 ac-
tivation, as well as upon TNF-α stimulation. Expression of miR-149-5p
was shown to be dependent on the expression of its host gene glypican-
1 (GPC1) [53], which itself is known to play a role in cell division and
growth regulation as it might lead to cancer [54,55]. The same holds
true for miR-149-5p. Downregulation of miR-149-5p is already asso-
ciated with various diseases, e.g. in the liver epithelial cancer cell line
NCI-N87, where miR-149-5p is called an anti-fitness miRNA due to its
downregulation [56]. Thereby, expression of this miRNA is associated
to tumour suppression, while its downregulation functions as bio-
marker for cancer [57]. However, only little is known regarding the
function of miR-149-5p and its host gene GPC1 in inflammation: GPC1
was described to be upregulated in a bacterial infection of oral epi-
thelial cells [58] and additionally, it was shown that miR-149-5p di-
rectly targets IL-6 (interleukin 6) in gastric cancer associated fibroblasts
or MYD88 (myeloid differentiation primary response 88) in LPS-treated
mouse macrophages [59,60].
Here, we show for the first time a direct correlation between miR-
149-5p and CHI3L1 in respiratory epithelial cell inflammation upon
TLR2, TLR3 and TNF-α signalling. Although it was demonstrated that
TNF-α stimulation reduces the expression of miR-149-5p via p38/
MAPK pathway in endothelial cells [61], our data indicated no reduc-
tion in CHI3L1 expression by inhibition of p38/MAPK or ERK1/2 in our
current model, but by inhibition of NF-κB translocation. Thus, we
speculate that TLR2- and TLR3-mediated down-regulation of miR-149-
5p and therefore activation of CHI3L1 expression in airway epithelial
cells is mainly dependent on TNF-α-mediated IκBα phosphorylation
and degradation to enable NF-κB translocation.
In this study, we provide evidence that overexpression of miR-149-
5p and thus the absence of CHI3L1 mRNA under TLR2 activation in
bronchial epithelial cells led to an increased CXCL8 expression. CHI3L1
addition itself to bronchial epithelial cells was not clearly able to induce
CXCL8 expression, which might depend on kinetic shifts. CXCL8 was
shown to be upregulated through CHI3L1 in human bronchial epithelial
cells leading to muscle cell proliferation [62]. Besides that, miR-149-5p
has been shown to interact with MYD88 to block its expression [60].
This would theoretically eliminate the MYD88-dependent signalling
necessary for TLR2-mediated NF-κB activation to induce CXCL8 ex-
pression [63,64]. However, CHI3L1 treatment reduced CXCL8 expres-
sion in a TNF-α-dependent manner in skeletal muscle cells [65],
pointing towards contradictory observations regarding CHI3L1-depen-
dent regulation of CXCL8 expression. Thus, the enhancement of cyto-
kine expression in miR-149-5p overexpressed and TLR2-activated cells
is not yet explicable and ought to be the focus of follow-up studies.
5. Conclusions
In conclusion, we identified an upregulation of CHI3L1 and a
downregulation of miR-149-5p in TLR2, TLR3- and TNF-α-activated
human bronchial epithelial cells. This regulatory effect was partially
dependent on TNF-α-mediated activation of NF-κB. While miR-149-5p
directly interacts with the 3`UTR of CHI3L1, inhibition and
Fig. 6. Inhibition and overexpression of miR-149-5p corre-
lates with expression levels of CHI3L1 in human bronchial
epithelial cells. BEAS-2B cells were transfected with (A, B, E)
miR-149-5p inhibitor (INH 149-5p), (C, D, F) miR-149-5p
mimic (MIM-149-5p) or a negative control (NEG) for 24 h and
stimulated with LTA (1 μg/mL) or mock-treated (CTR) for
additional 24 h. Quantification of expression of (A, C) miR-
149-5p, (B, D) CHI3L1 mRNA and (E, F) CHI3L1 protein re-
lease was performed using quantitative RT-PCR or ELISA,
respectively. Expression was normalized to endogenous
RNU48 for miRNA or GAPDH for mRNA and unstimulated
control. N=3–4. Stats were calculated using log2-trans-
formed data. Two-way ANOVA using Holm-Sidak multiple
comparisons test. *p < .05; **p < .01; ***p < .001;
****p < .0001. Shown are floating bars with line at mean.
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overexpression of miR-149-5p changed expression levels of CHI3L1
mRNA in bronchial epithelial cells. Altogether, our findings underline a
tight and interconnected regulatory network of inflammation-mediated
signalling and miRNA function on CHI3L1 in human bronchial epithe-
lial cells, providing a potential target for therapeutic interventions.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.cellsig.2019.109498.
Declaration of Competing Interest
None.
Acknowledgements
We are grateful to Ronny Kellner for comments on the manuscript
and thank all laboratory members for valuable discussions.
This work has been funded in part by the Bundesministerium für
Bildung und Forschung (Federal Ministry of Education and Research,
JPI-AMR – FKZ 01KI1702; ERACoSysMed2 – SysMed-COPD – FKZ
031L0140; e:Med CAPSYS – FKZ 01ZX1604E), the Deutsche
Forschungsgemeinschaft (SFB/TR84 TRR84/3), the Von-Behring-
Röntgen-Stiftung (66-LV07), and the Hessisches Ministerium für
Wissenschaft und Kunst (LOEWE Medical RNomics 519/03/00.001-
[0003]) to B. S. The funding sources were not involved in the study.
References
[1] C. Feldman, R. Anderson, The role of Streptococcus pneumoniae in community-
acquired pneumonia, Semin Respir Crit Care Med 37 (6) (2016) 806–818.
[2] C. Peteranderl, S. Herold, C. Schmoldt, Human influenza virus infections, Semin
Respir Crit Care Med 37 (4) (2016) 487–500.
[3] R. Medzhitov, C. Janeway Jr., Innate immunity, N. Engl. J. Med. 343 (5) (2000)
338–344.
[4] A. Ray, et al., Bacterial cell wall macroamphiphiles: pathogen−/microbe-asso-
ciated molecular patterns detected by mammalian innate immune system,
Biochimie 95 (1) (2013) 33–42.
[5] M. Yu, S.J. Levine, Toll-like receptor, RIG-I-like receptors and the NLRP3 in-
flammasome: key modulators of innate immune responses to double-stranded RNA
viruses, Cytokine Growth Factor Rev. 22 (2) (2011) 63–72.
[6] J. Krishnan, et al., Toll-like receptor signal transduction, Exp. Mol. Med. 39 (4)
(2007) 421–438.
[7] G. Zhao, et al., Polydatin reduces Staphylococcus aureus lipoteichoic acid-induced
injury by attenuating reactive oxygen species generation and TLR2-NF kappa B
signalling, J. Cell. Mol. Med. 21 (11) (2017) 2796–2808.
[8] B. Schmeck, et al., Pneumococci induced TLR- and Rac1-dependent NF-kappaB-
recruitment to the IL-8 promoter in lung epithelial cells, Am. J. Phys. Lung Cell.
Mol. Phys. 290 (4) (2006) L730–L737.
[9] T. Shuto, et al., Activation of NF-kappa B by nontypeable Hemophilus influenzae is
mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B
alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells, Proc.
Natl. Acad. Sci. U. S. A. 98 (15) (2001) 8774–8779.
[10] Y. Wang, et al., Dimerization of toll-like receptor 3 (TLR3) is required for ligand
binding, J. Biol. Chem. 285 (47) (2010) 36836–36841.
[11] M. Tatematsu, T. Seya, M. Matsumoto, Beyond dsRNA: toll-like receptor 3 signalling
in RNA-induced immune responses, Biochem. J. 458 (2) (2014) 195–201.
[12] F.D. Coffman, Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the inter-
face of proteomics and glycomics, Crit. Rev. Clin. Lab. Sci. 45 (6) (2008) 531–562.
[13] M. Prakash, et al., Diverse pathological implications of YKL-40: answers may lie in
'outside-in' signaling, Cell. Signal. 25 (7) (2013) 1567–1573.
[14] S. Libreros, R. Garcia-Areas, V. Iragavarapu-Charyulu, CHI3L1 plays a role in cancer
through enhanced production of pro-inflammatory/pro-tumorigenic and angio-
genic factors, Immunol. Res. 57 (1–3) (2013) 99–105.
[15] M.H. Kazakova, et al., YKL-40 and cytokines - a new diagnostic constellation in
rheumatoid arthritis? Folia Med (Plovdiv) 59 (1) (2017) 37–42.
[16] C. Hobaus, et al., YKL-40 levels increase with declining ankle-brachial index and are
associated with long-term cardiovascular mortality in peripheral arterial disease
patients, Atherosclerosis 274 (2018) 152–156.
[17] B.E. Hakala, C. White, A.D. Recklies, Human cartilage gp-39, a major secretory
product of articular chondrocytes and synovial cells, is a mammalian member of a
chitinase protein family, J. Biol. Chem. 268 (34) (1993) 25803–25810.
[18] D. Low, et al., High endogenous expression of Chitinase 3-like 1 and excessive
epithelial proliferation with colonic tumor formation in MOLF/EiJ mice, PLoS One
10 (10) (2015) e0139149.
[19] D. Low, et al., Chitinase 3-like 1 induces survival and proliferation of intestinal
epithelial cells during chronic inflammation and colitis-associated cancer by reg-
ulating S100A9, Oncotarget 6 (34) (2015) 36535–36550.
[20] L. Maegdefessel, et al., miR-24 limits aortic vascular inflammation and murine
abdominal aneurysm development, Nat. Commun. 5 (2014) 5214.
[21] M. Kawada, et al., Chitinase 3-like-1 enhances bacterial adhesion to colonic epi-
thelial cells through the interaction with bacterial chitin-binding protein, Lab.
Investig. 88 (8) (2008) 883–895.
[22] R. Bhardwaj, et al., RelB/p50 complexes regulate cytokine-induced YKL-40 ex-
pression, J. Immunol. 194 (6) (2015) 2862–2870.
[23] C.S. Dela Cruz, et al., Chitinase 3-like-1 promotes Streptococcus pneumoniae killing
and augments host tolerance to lung antibacterial responses, Cell Host Microbe 12
(1) (2012) 34–46.
[24] N. Gao, F.S. Yu, Chitinase 3-like 1 promotes Candida albicans killing and preserves
corneal structure and function by controlling host antifungal responses, Infect.
Immun. 83 (10) (2015) 4154–4164.
[25] Y. Zhou, et al., Chitinase 3-like 1 suppresses injury and promotes fibroproliferative
responses in mammalian lung fibrosis, Sci. Transl. Med. 6 (240) (2014) 240ra76.
[26] D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell 116
(2) (2004) 281–297.
[27] J. O'Brien, et al., Overview of MicroRNA biogenesis, mechanisms of actions, and
Circulation, Front Endocrinol (Lausanne) 9 (2018) 402.
[28] J. Han, et al., The Drosha-DGCR8 complex in primary microRNA processing, Genes
Dev. 18 (24) (2004) 3016–3027.
[29] Y. Lee, et al., The nuclear RNase III Drosha initiates microRNA processing, Nature
425 (6956) (2003) 415–419.
[30] A.M. Denli, et al., Processing of primary microRNAs by the microprocessor com-
plex, Nature 432 (7014) (2004) 231–235.
[31] R.I. Gregory, et al., The microprocessor complex mediates the genesis of
microRNAs, Nature 432 (7014) (2004) 235–240.
[32] M. Landthaler, A. Yalcin, T. Tuschl, The human DiGeorge syndrome critical region
gene 8 and its D. melanogaster homolog are required for miRNA biogenesis, Curr.
Biol. 14 (23) (2004) 2162–2167.
[33] S. Bagga, et al., Regulation by let-7 and lin-4 miRNAs results in target mRNA de-
gradation, Cell 122 (4) (2005) 553–563.
[34] L.P. Lim, et al., Microarray analysis shows that some microRNAs downregulate
large numbers of target mRNAs, Nature 433 (7027) (2005) 769–773.
[35] R.S. Pillai, S.N. Bhattacharyya, W. Filipowicz, Repression of protein synthesis by
miRNAs: how many mechanisms? Trends Cell Biol. 17 (3) (2007) 118–126.
[36] K.D. Taganov, et al., NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl.
Acad. Sci. U. S. A. 103 (33) (2006) 12481–12486.
[37] N.J. Sarma, et al., Hepatitis C virus mediated changes in miRNA-449a modulates
inflammatory biomarker YKL40 through components of the NOTCH signaling
pathway, PLoS One 7 (11) (2012) e50826.
[38] T. Jin, et al., The role of MicroRNA, miR-24, and its target CHI3L1 in osteomyelitis
caused by Staphylococcus aureus, J. Cell. Biochem. 116 (12) (2015) 2804–2813.
[39] Z. Jingjing, et al., MicroRNA-24 modulates Staphylococcus aureus-induced mac-
rophage polarization by suppressing CHI3L1, Inflammation 40 (3) (2017)
995–1005.
[40] M. Hashimoto, et al., Not lipoteichoic acid but lipoproteins appear to be the
dominant immunobiologically active compounds in Staphylococcus aureus, J.
Immunol. 177 (5) (2006) 3162–3169.
[41] K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-
time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods 25 (4)
(2001) 402–408.
[42] M. Hashimoto, et al., Not lipoteichoic acid but lipoproteins appear to be the
dominant immunobiologically active compounds in Staphylococcus aureus, J.
Immunol. 177 (5) (2006) 3162–3169.
[43] A.K. Field, et al., Inducers of interferon and host resistance. II. Multistranded syn-
thetic polynucleotide complexes, Proc. Natl. Acad. Sci. U. S. A. 58 (3) (1967)
1004–1010.
[44] J.W. Pierce, et al., Novel inhibitors of cytokine-induced IkappaBalpha phosphor-
ylation and endothelial cell adhesion molecule expression show anti-inflammatory
effects in vivo, J. Biol. Chem. 272 (34) (1997) 21096–21103.
[45] E.M. Quinn, et al., MicroRNA-146a is upregulated by and negatively regulates TLR2
signaling, PLoS One 8 (4) (2013) e62232.
[46] https://www.who.int/news-room/fact-sheets/detail/pneumonia (2nd August
2019).
[47] E. Meylan, et al., RIP1 is an essential mediator of toll-like receptor 3-induced NF-
kappa B activation, Nat. Immunol. 5 (5) (2004) 503–507.
[48] V. Tergaonkar, et al., Distinct roles of IkappaB proteins in regulating constitutive
NF-kappaB activity, Nat. Cell Biol. 7 (9) (2005) 921–923.
[49] S. Saccani, S. Pantano, G. Natoli, p38-dependent marking of inflammatory genes for
increased NF-kappa B recruitment, Nat. Immunol. 3 (1) (2002) 69–75.
[50] S. Saccani, S. Pantano, G. Natoli, Two waves of nuclear factor kappaB recruitment
to target promoters, J. Exp. Med. 193 (12) (2001) 1351–1359.
[51] Recklies, A.D., C. White, and H. Ling, The chitinase 3-like protein human cartilage
glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells
and activates both extracellular signal-regulated kinase- and protein kinase B-
mediated signalling pathways. Biochem. J., 2002. 365(Pt 1): p. 119–26.
[52] S. Scully, et al., Inhibitory activity of YKL-40 in mammary epithelial cell differ-
entiation and polarization induced by lactogenic hormones: a role in mammary
tissue involution, PLoS One 6 (10) (2011) e25819.
[53] A. Chamorro-Jorganes, et al., Autoregulation of glypican-1 by intronic microRNA-
149 fine tunes the angiogenic response to FGF2 in human endothelial cells, J. Cell
Sci. 127 (Pt 6) (2014) 1169–1178.
[54] J. Li, et al., Glypican-1 promotes tumorigenesis by regulating the PTEN/Akt/beta-
catenin Signaling pathway in Esophageal squamous cell carcinoma, Dig. Dis. Sci. 64
(6) (2019) 1493–1502.
K. Hübner, et al. Cellular Signalling 67 (2020) 109498
9
[55] D. Qiao, et al., Glypican-1 regulates anaphase promoting complex/cyclosome sub-
strates and cell cycle progression in endothelial cells, Mol. Biol. Cell 19 (7) (2008)
2789–2801.
[56] J.S. Kurata, R.J. Lin, MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-
associated miRNAs, RNA 24 (7) (2018) 966–981.
[57] Y. He, et al., miR-149 in Human Cancer: A Systemic Review, J. Cancer 9 (2) (2018)
375–388.
[58] G. Zhang, J.D. Rudney, Streptococcus cristatus attenuates Fusobacterium nucle-
atum-induced cytokine expression by influencing pathways converging on nuclear
factor-kappaB, Mol Oral Microbiol 26 (2) (2011) 150–163.
[59] P. Li, et al., Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts
mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment,
Cell Res. 25 (5) (2015) 588–603.
[60] G. Xu, et al., MicroRNA-149 negatively regulates TLR-triggered inflammatory re-
sponse in macrophages by targeting MyD88, J. Cell. Biochem. 115 (5) (2014)
919–927.
[61] D. Palmieri, et al., TNFalpha induces the expression of genes associated with en-
dothelial dysfunction through p38MAPK-mediated down-regulation of miR-149,
Biochem. Biophys. Res. Commun. 443 (1) (2014) 246–251.
[62] H. Tang, et al., YKL-40 induces IL-8 expression from bronchial epithelium via MAPK
(JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle pro-
liferation and migration, J. Immunol. 190 (1) (2013) 438–446.
[63] O. Takeuchi, K. Hoshino, S. Akira, Cutting edge: TLR2-deficient and MyD88-defi-
cient mice are highly susceptible to Staphylococcus aureus infection, J. Immunol.
165 (10) (2000) 5392–5396.
[64] O. Takeuchi, et al., Cellular responses to bacterial cell wall components are medi-
ated through MyD88-dependent signaling cascades, Int. Immunol. 12 (1) (2000)
113–117.
[65] S.W. Gorgens, et al., Chitinase-3-like protein 1 protects skeletal muscle from
TNFalpha-induced inflammation and insulin resistance, Biochem. J. 459 (3) (2014)
479–488.
K. Hübner, et al. Cellular Signalling 67 (2020) 109498
10
